Continued growth Roughly a third of the S&P 500 index have seen steady or rapid growth during the pandemic.
Semiconductor, retail and pharmaceutical companies fared the best compared with other sectors. Companies in biotech saw some of the largest revenue percentage growth in pharmaceuticals, biotechnology and life sciences.
Moderna Inc. had the largest revenue increase among the entire S&P 500. The company’s revenue increased 33,187% from the second quarter of 2019 to 2021—a figure too large to include in our charts.
Regeneron Pharmaceuticals Inc.’s revenues jumped 165.7% in the second quarter of 2021, largely thanks to its use of experimental treatment for Covid-19.